Responsive Image

 

 

Responsive Image

Investigación en genética y control de diabetes y enfermedades endocrinas

Foto grupo

Coordinador/a del grupo



Miembros del grupo

  Alejandro García Castaño
 
  |   847280
  Anibal Aguayo Calcena
 
 
  María Victoria Aparicio Prieto
 
 
  Patricia Aspichueta Celaa
 
  Igor Aurrekoetxea Galindo
 
  Alicia Cortazar Galarza
 
 
  Concepción Fernández Ramos
 
 
  Arturo Galbarriatu Gutierrez
 
 
  Maria Sonia Gaztambide Saenz
 
 
  Pedro González Fernández
 
 
  Itziar González Moro
 
  Gema Grau Bolado
 
 
  Paloma Jimenez Huertas
 
 
  Rosa María Martínez Salazar
 
  |   842435
  Idoia Martínez de La Piscina Martín
 
  |   844741
  María Dolores Moure Rodríguez
 
 
  Itxaso Rica Etxebarria
 
 
  María Concepción Rivero Martínez
 
  |   846473
  Amaya Rodríguez Estévez
 
 
  Izortze Santín Gómez
 
 
  Javier Santamaría Sandi
 
 
  Laura Saso Jiménez
 
 
  Ane Urbina Juez
 
 
  Inés Urrutia Echevarria
 
  |   842435
  Luis Vega González
 
  Amaya Vela Desojo
 
 
  Olaia Velasco Vielba
 
 
  Ana Villalba Cabrera
 
 
  Amelia Oleaga Alday
 
 
  Jon Mentxaka Salgado
 
 
  Miriam Sánchez Morán
 
 
  Vanessa Arosa Carril
 
 
  Alicia Martín Nieto
 
 
  Elsa Fernández Rubio
 
 
  Virginia Agudo Endemaño
 
 
  June Corcuera Tejada
 
 
  María Begoña Quintas Gómez
 
 
  Amaya Hidalgo Murillo
 
 
  Estrella Diego Perojo
 
 
  Ignacio Valverde Benítez
 
 
  Candela Baquero Martínez
 
 
  Ainhoa Camille Aranaga Decori
 
 
  Naroa Campo Olano
 
 
  Leire Bergara Muguruza
 
  Iván Carlos Cárcamo Oribe
 
  Nuria Valdés Gallego
 
 

Publicaciones del grupo

Gonzalez Fernandez P, Grau Bolado G, Fernandez Lopez C, Ponce de Leon Saenz de Navarrete S, Guadilla Fernandez ML, Vazquez San Miguel F, et al. Changing trends in transgender demographics and morbidity: baseline data from a Spanish cohort. Sex Health. 2023; 20(1): 96-98. DOI:10.1071/SH22171.

Gonzalez Moro I, Rojas Marquez H, Sebastian delaCruz M, Mentxaka Salgado J, Olazagoitia Garmendia A, Mendoza LM, et al. A long non-coding RNA that harbors a SNP associated with type 2 diabetes regulates the expression of TGM2 gene in pancreatic beta cells. Front Endocrinol. 2023; 14: 1101934-1101934. DOI:10.3389/fendo.2023.1101934.

Biagetti B, Iglesias P, Villar Taibo R, Moure M, Paja M, Araujo Castro M, et al. Mortality in acromegaly diagnosed in the elderly in Spain is higher in women compared to the general Spanish population. J Clin Endocrinol Metab. 2023. DOI:10.1210/clinem/dgad141.

Lavin B, Eykyn TR, Phinikaridou A, Xavier A, Kumar S, Buqué X, et al. Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS-/- mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. NMR Biomed. 2023; 36(8): 4932-4932. DOI:10.1002/nbm.4932.

Perez Fernandez L, Sastre J, Zafon C, Oleaga A, Castelblanco E, Capel I, et al. Validation of dynamic risk stratification and impact of BRAF in risk assessment of thyroid cancer, a nation-wide multicenter study. Front Endocrinol. 2023; 13. DOI:10.3389/fendo.2022.1071775.

Hirschler V, Gonzalez C, Rica I, Lapertosa S, Urrutia I, Martinez Salazar R, et al. Hepcidin is associated directly with inflammatory markers and inversely with glucose in Indigenous Argentinean children. Horm Res Paediatr. 2023; 96(SUPPL 2): 32-33

Contreras A, Pino C, Garcia H, Loureiro C, Castano L. Severe craneosynostosis in non-autoimmune neonatal hyperthyroidism, suspected tshr activating mutation, a case report. Horm Res Paediatr. 2023; 96(SUPPL 2): 142-142

Martinez de lapiscina I, Kouri C, Aurrekoetxea J, Sanchez M, Naamneh R, Sommer G, et al. Uncovering the role of the SF-1/NR5A1 p.Gly146Ala variant for the phenotype of DSD patients. Horm Res Paediatr. 2023; 96(SUPPL 2): 39-39

Kouri C, Sommer G, De Lapiscina IM, Tack L, Cools M, Flück CE, et al. Birth weight and height in individuals with SF-1/ NR5A1 variants: Results from the international SF1next study. Horm Res Paediatr. 2023; 96(SUPPL 2): 129-129

Elzenaty RN, De Lapiscina IM, Kouri C, Sommer G, Fluck CE. Pathogenicity testing of fifteen novel missense SF-1/NR5A1 variants in DSD patients. Horm Res Paediatr. 2023; 96(SUPPL 2): 136-136

Valassi E, Manichanh C, Amodru V, Fernandez PG, Gaztambide S, Yanez F, et al. Gut microbial dysbiosis in patients with Cushing's disease in long-term remission. Relationship with cardiometabolic risk. Front Endocrinol. 2023; 14. DOI:10.3389/fendo.2023.1074757.

Gonzalez Moro I, Garcia Etxebarria K, Mendoza LM, Fernandez Jimenez N, Mentxaka J, Olazagoitia Garmendia A, et al. LncRNA ARGI Contributes to Virus-Induced Pancreatic ß Cell Inflammation Through Transcriptional Activation of IFN-Stimulated Genes. Adv Sci. 2023; 10(25). DOI:10.1002/advs.202300063.

Urrutia I, Martinez R, Calvo B, Saso Jimenez L, Gonzalez P, Fernandez Rubio E, et al. Autoimmune Diabetes From Chilhood to Adulthood: The Role of Pancreatic Autoantibodies and HLA-DRB1 Genotype. J Clin Endocrinol Metab. 2023. DOI:10.1210/clinem/dgad277.

Ruiz Garcia I, Sanchez Torralvo FJ, Gomez Zumaquero JM, Colomo Rodriguez N, Dominguez Lopez M, Saso Jimenez L, et al. SHORT syndrome: A good case can break an old acronym. Endocrinol Diabetes Nutr. 2023; 70(3): 220-222. DOI:10.1016/j.endinu.2022.11.009.

Alonso Rubio P, Bahillo Curieses MP, Prieto Matos P, Bertholt Zuber ML, Martin Alonso MM, Murillo Valles M, et al. Adaptation, reliability and validity of health-related quality of life questionnaires: Disabkids chronic and specific diabetes disease in children and adolescents with diabetes mellitus type 1. Endocrinol Diabetes Nutr. 2023; 70 Suppl 3: 18-26. DOI:10.1016/j.endien.2023.07.004.

Capelo Diz A, Lachiondo Ortega S, Fernández Ramos D, Canas Martin J, Goikoetxea Usandizaga N, Serrano Maciá M, et al. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting. Cell Metab. 2023; 35(8). DOI:10.1016/j.cmet.2023.07.002.

Sainz de Los Terreros Errea A, Madariaga L, Garcia Castano A. Hypercalcemia in patients with mutations in NR3C2 and SCNN1B. Med Clin. 2023; 161(10). DOI:10.1016/j.medcli.2023.06.041.

Garcia Castano A, Gomez Conde S, Gondra L, Herrero M, Aguirre M, de la Hoz A, et al. Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3. Sci Rep. 2023; 13(1). DOI:10.1038/s41598-023-38179-6.

Marsal Beltran A, Rodríguez Castellano A, Astiarraga B, Calvo E, Rada P, Madeira A, et al. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD. Metab-Clin Exp. 2023; 145. DOI:10.1016/j.metabol.2023.155630.

Noureddin M, Truong E, Mayo R, Martinez Arranz I, Minchole I, Banales JM, et al. Serum identification of At-Risk MASH: The Metabolomics-Advanced steatohepatitis fibrosis score (MASEF). Hepatology. 2023; 79(1): 135-148. DOI:10.1097/HEP.0000000000000542.

Martinez de LaPiscina I, Kouri C, Aurrekoetxea J, Sanchez M, Naamneh Elzenaty R, Sauter K, et al. Genetic reanalysis of patients with a difference of sex development carrying the NR5A1/SF-1 variant p.Gly146Ala has discovered other likely disease-causing variations. PLoS One. 2023; 18(7). DOI:10.1371/journal.pone.0287515.

Aurrekoetxea I, Gomez Santos B, Apodaka Biguri M, Ruiz de Gauna M, Gonzalez Romero F, Buque X, et al. In Vivo Tissue Lipid Uptake in Antisense Oligonucleotide (ASO)-Treated Mice. Methods Mol Biol. 2023; 2675: 1-13. DOI:10.1007/978-1-0716-3247-5_1.

Gomez Santos B, Saenz de Urturi D, Buque X, Aurrekoetxea I, Nieva A, Fernandez Puertas I, et al. In Vivo Hepatic Triglyceride Secretion Rate in Antisense Oligonucleotide (ASO)-Treated Mice. Methods Mol Biol. 2023; 2675: 15-26. DOI:10.1007/978-1-0716-3247-5_2.

Mendoza Gomez LM, Sebastian delaCruz M, Olazagoitia Garmendia A, Gonzalez Moro I, Rojas Marquez H, Mentxaka J, et al. Preparation of pepsin trypsin digested gliadin for stimulation experiments. METHOD CELL BIOL. 2023; 179: 195-201. DOI:10.1016/bs.mcb.2022.11.005.

Gomez Peralta F, Menendez E, Conde S, Conget I, Novials A, Olmedo IS, et al. Physical activity patterns in type 1 diabetes in Spain: The SED1 study. BMC Sports Sci Med Rehabil. 2023; 15(1). DOI:10.1186/s13102-023-00695-3.

Santamaria J, Breton I, Fernandez A, Hanzu F, Luque R, Pines P, et al. RECALSEEN 2021. Resources and quality in the Endocrinology and Nutrition units of the National Health System of Spain. Endocrinol Diabetes Nutr. 2023; 70(7): 459-467. DOI:10.1016/j.endien.2023.03.022.

Valdes S, Doulatram Gamgaram V, Maldonado Araque C, Garcia Escobar E, Garcia Serrano S, Oualla Bachiri W, et al. Association between exposure to air pollution and blood lipids in the general population of Spain. Eur J Clin Invest. 2023: 14101-14101. DOI:10.1111/eci.14101.

Gomez Peralta F, Valledor X, Lopez Picado A, Abreu C, Fernandez Rubio E, Cotovad L, et al. Ultrarapid insulin use can reduce postprandial hyperglycemia and late hypoglycemia, even in delayed insulin injections. A connected insulin cap-based real-world study. Diabetes Technol Ther. 2023. DOI:10.1089/dia.2023.0321.

Manka P, Coombes JD, Sydor S, Swiderska Syn MK, Best J, Gauthier K, et al. Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells. Liver Int. 2023. DOI:10.1111/liv.15759.

Urritia I, Martinez R, Calvo B, Saso Jimenez L, Gonzalez P, Fernandez Rubio E, et al. Autoimmune Diabetes From Chilhood to Adulthood: The Role of Pancreatic Autoantibodies and HLA-DRB1 Genotype (vol 108, pg e1341, 2023). J Clin Endocrinol Metab. 2023. DOI:10.1210/clinem/dgad609.

Ochoa E, Lee S, Lan Leung B, Dias RP, Ong KK, Radley JA, et al. ImprintSeq, a novel tool to interrogate DNA methylation at human imprinted regions and diagnose multilocus imprinting disturbance. Genet Med. 2022; 24(2): 463-474. DOI:10.1016/j.gim.2021.10.011.

Ruiz de Gauna M, Biancaniello F, Gonzalez Romero F, Rodrigues PM, Lapitz A, Gomez Santos B, et al. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids. Hepatology. 2022; 76(6): 1617-1633. DOI:10.1002/hep.32344.

Jebari Benslaiman S, Uribe KB, Benito Vicente A, Galicia Garcia U, Larrea Sebal A, Santin I, et al. Boosting Cholesterol Efflux from Foam Cells by Sequential Administration of rHDL to Deliver MicroRNA and to Remove Cholesterol in a Triple-Cell 2D Atherosclerosis Model. Small. 2022; 18(13). DOI:10.1002/smll.202105915.

Sot J, Garcia Arribas AB, Abad B, Arranz S, Portune K, Andrade F, et al. Erythrocyte Membrane Nanomechanical Rigidity Is Decreased in Obese Patients. Int J Mol Sci. 2022; 23(3). DOI:10.3390/ijms23031920.

Vazquez Mosquera ME, Gonzalez Vioque E, Barbosa Gouveia S, Bellido Guerrero D, Tejera Perez C, Martinez Olmos MA, et al. Transcriptomic analysis of patients with clinical suspicion of maturity-onset diabetes of the young (MODY) with a negative genetic diagnosis. Orphanet J Rare Dis. 2022; 17(1). DOI:10.1186/s13023-022-02263-3.

de Urturi DS, Buque X, Porteiro B, Folgueira C, Mora A, Delgado TC, et al. Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis. Nat Commun. 2022; 13(1): 1096-1096. DOI:10.1038/s41467-022-28749-z.

Olaizola P, Lee Law PY, Fernandez Barrena MG, Alvarez L, Cadamuro M, Azkargorta M, et al. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumors-stroma crosstalk in experimental models. J Hepatol. 2022; 77(1): 177-190. DOI:10.1016/j.jhep.2022.02.007.

Gomez Munoz L, Perna Barrull D, Caroz Armayones JM, Murillo M, Rodriguez Fernandez S, Valls A, et al. Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes. Front Immunol. 2022; 13. DOI:10.3389/fimmu.2022.825426.

Ochoa E, Lee S, Lan Leung B, Dias R, Ong KK, Radley JA, et al. New diagnostic tool for multi-locus imprinting disturbances. Eur J Hum Genet. 2022; 30(SUPPL 1): 549-550

Moral Martos A, Guerrero Fernandez J, Gomez Balaguer M, Rica Echevarria I, Campos Martorell A, Chueca Guindulain MJ, et al. Clinical practice guidelines for transsexual, transgender and gender diverse minors. An Pediatr (Engl Ed). 2022; 96(4): 3491-34911. DOI:10.1016/j.anpede.2022.02.002.

Castano L, Madariaga L, Grau G, Garcia Castano A. 25(OH)Vitamin D Deficiency and Calcifediol Treatment in Pediatrics. Nutrients. 2022; 14(9). DOI:10.3390/nu14091854.

Exposito Rodriguez A, Corta Gomez I, Dominguez Ayala M, Garcia Carrillo M, Gonzalez Garcia AI, Gutierrez Rodriguez MT, et al. Sentinel lymph node biopsy in papillary thyroid cancer: Accuracy and application in clinical practice. Cir Esp (Engl Ed). 2022; 100(7): 416-421. DOI:10.1016/j.cireng.2022.04.022.

Olaizola P, Rodrigues PM, Caballero Camino FJ, Izquierdo Sanchez L, Aspichueta P, Bujanda L, et al. Genetics, pathobiology and therapeutic opportunities of polycystic liver disease. Nat Rev Gastroenterol Hepatol. 2022; 19(9): 585-604. DOI:10.1038/s41575-022-00617-7.

Nowak C, Lind M, Sumnik Z, Pelikanova T, Chavez LN, Lundberg E, et al. Intralymphatic GAD-alum (Diamyd) improves glycaemic control in Type 1 diabetes with HLA DR3-DQ2. J Clin Endocrinol Metab. 2022; 107(9): 2644-2651. DOI:10.1210/clinem/dgac343.

Gonzalez Fenandez M, Antonio IED, Martin IMP, Martinez JS, Almaraz MCA. 5-Alpha-reductase type 2 deficiency. A new case in the Spanish population. Endocrinol Diabetes Nutr. 2022; 69(5): 384-386. DOI:10.1016/j.endien.2021.04.002.

Cruz R, Almeida SD, Heredia ML, Quintela I, Ceballos FC, Pita G, et al. Novel genes and sex differences in COVID-19 severity. Hum Mol Genet. 2022. DOI:10.1093/hmg/ddac132.

Labiano I, Agirre Lizaso A, Olaizola P, Echebarria A, Huici Izagirre M, Olaizola I, et al. TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation. J Hepatol. 2022; 77(4): 991-1004. DOI:10.1016/j.jhep.2022.05.044.

Garcia Perez J, Gonzalez Perez M, Castillo de la Osa M, Borobia AM, Castano L, Bertran MJ, et al. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study. Eclinicalmedicine. 2022; 50: 101529-101529. DOI:10.1016/j.eclinm.2022.101529.

Ruiz de Gauna M, Biancaniello F, Gonzalez Romero F, Miguel Rodrigues P, Lapitz A, Gomez Santos B, et al. The uptake of extracellular lipids promotes cholangiocarcinoma progression. J Hepatol. 2022; 77: 648-648

Del Barrio Azaceta M, Iruzubieta P, Aller de la Fuente R, Maria Banales J, Santos Laso A, Calleja Panero JL, et al. The metabolic dysfunction-associated fatty liver disease definition, regardless of its clinical subclassification, identifies patients at high risk for liver disease progression. J Hepatol. 2022; 77: 158-159

Gomez Santos B, Fernamdez Puertas I, Nieva Zuluaga A, Ruiz de Gauna M, Apodaka Biguri M, Gonzalez Romero F, et al. The DNA damage response is involved in the metabolic dysregulation of MAFLD patients via inefficient fatty acid oxidation. J Hepatol. 2022; 77: 665-665

Olaizola P, Lee Law P, Fernandez Barrena MG, Alvarez L, Cadamuro M, Azkargorta M, et al. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumour-stroma crosstalk in experimental models. J Hepatol. 2022; 77: 46-46

Apodaka Biguri M, Gonzalez Romero F, Mestre Congregado D, Aurrekoetxea I, Gomez Santos B, Delgado I, et al. miR34a-5p is a target of E2F2 transcription factor in MAFLD-related HCC. J Hepatol. 2022; 77: 651-652

Buque X, Porteiro B, Folgueira C, Mora A, Cardoso Delgado T, Prieto Fernandez E, et al. Methionine adenosyltransferase 1a antisense oligonucleotides induce the fibroblast growth factor 21-driven recovery from obesity and associated hepatoesteatosis. J Hepatol. 2022; 77: 689-690

Del Barrio Azaceta M, Iruzubieta P, Aller De La Fuente R, Maria Banales J, Santos Laso A, Calleja Panero JL, et al. Metabolic dysfunction-associated fatty liver disease increases cardiovascular risk regardless of classical risk factors. J Hepatol. 2022; 77: 157-157

Vallejo Casas JA, Sambo M, Lopez C, Duran Poveda M, Rodriguez Villanueva Garcia J, Santos RJ, et al. Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study. Eur Thyroid J. 2022; 11(5). DOI:10.1530/ETJ-21-0111.

Diez JJ, Anda E, Alcazar V, Isidro ML, Familiar C, Paja M, et al. Differentiated thyroid carcinoma in the elderly: influence of age on disease-free and overall survival. Endocrine. 2022; 77(1): 121-133. DOI:10.1007/s12020-022-03059-y.

Valdes S, Doulatram Gamgaram V, Maldonado Araque C, Lago Sampedro A, Garcia Escobar E, Garcia Serrano S, et al. Ambient air pollution and thyroid function in Spanish adults. A nationwide population-based study (Di@bet.es study). Environ Health. 2022; 21(1). DOI:10.1186/s12940-022-00889-1.

Lago Sampedro A, Lhamyani S, Valdes S, Colomo N, Maldonado Araque C, Gonzalez Molero I, et al. Serum vascular endothelial growth factor b and metabolic syndrome incidence in the population based cohort Di@bet.es study. Int J Obes. 2022; 46(11): 2013-2020. DOI:10.1038/s41366-022-01212-1.

Garcia E, Alvarez Del Vayo C, Castano L. Familial male-limited precocious puberty (testotoxicosis): Usefulness of treatment with ketoconazole and triptorelin. Med Clin. 2022; 159(11): 79-80. DOI:10.1016/j.medcli.2022.08.007.

Kouri C, Sommer G, Martinez de LaPiscina I, Tack L, Cools M, Flueck CE. The international SF1 next project: Description of a cohort of 107 individuals with SF-1/NR5A1 variants. Sex Dev. 2022; 16(SUPPL 1): 23-24

Martinez de LaPiscina I, Kouri C, Sommer G, Tack L, Cools M, Flueck CE, et al. Spectrum of SF-1/NR5A1 gene variants in the large international SF1next cohort. Sex Dev. 2022; 16(SUPPL 1): 65-66

Garcia Castano A, Gomez Conde S, Madariaga L, Ariceta G. NEW FAMILY WITH KCNJ16 GENE TUBULOPATHY, CHARACTERIZED BY HYPOKALEMIA, IMPAIRED ACID-BASE HOMEOSTASIS AND SENSORINEURAL HEARING LOSS. Pediatr Nephrol. 2022; 37(11): 2874-2875

Mendizabal L, Arregi M, Deogracia JV, Levi AMR, Barabash A, De la Torre NG, et al. New Gestational Diabetes Mellitus Risk Algorithm. Diabetes. 2022; 71. DOI:10.2337/db22-156-LB.

Biagetti B, Iglesias P, Villar Taibo R, Moure M, Paja M, Araujo Castro M, et al. Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain. Front Endocrinol. 2022; 13: 984877-984877. DOI:10.3389/fendo.2022.984877.

Hamidi M, Eriz A, Mitxelena J, Fernandez Ares L, Aurrekoetxea I, Aspichueta P, et al. Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity. Cancers (Basel). 2022; 14(19). DOI:10.3390/cancers14194952.

de LaPiscina IM, Kouri C, Sommer G, Tack L, Cools M, Fluck C, et al. SF1next study: spectrum of SF-1/NR5A1 gene variants in this large international cohort. Horm Res Paediatr. 2022; 95(SUPPL 2): 109-109

Grau G, Andrade F, Vela A, Lopez Oceja R, Rica I. Bisphenol A (BPA): A hidden enemy. Horm Res Paediatr. 2022; 95(SUPPL 2): 536-536

Kouri C, Sommer G, Martinez de LaPiscina I, Tack L, Cools M, Fluck CE, et al. Phenotypes in a large international cohort of individuals with SF-1/NR5A1 variants. Horm Res Paediatr. 2022; 95(SUPPL 2): 46-46

Marcelo I, Urrutia I, Calvo B, Martinez R, Saso L, Castano L, et al. Prevalence of autoimmunity in relatives of patients with type 1 diabetes: Time to the clinical onset of diabetes and associated risk factors. Horm Res Paediatr. 2022; 95(SUPPL 2): 177-178

Hirschler V, Gonzalez CD, Itxaso R, Ines U, Zalazar Rosa M, Anibal A, et al. Association between Hepcidin and Type 2 Diabetes markers In Indigenous Argentinean Children living at High Altitude. Clin Chim Acta. 2022; 537: 194-198. DOI:10.1016/j.cca.2022.08.021.

Nunez Munoz R, Ortega YC, Sarmiento M, Jorge RV, Fuentes AP, Subirats JG, et al. Stimulated thyroglobulin ( TG) prior to [131I] therapy (RAIT) in patients with differentiated thyroid cancer (DTC) as a predictive factor of recurrence. Eur J Nucl Med Mol Imaging. 2022; 49(SUPPL 1): 586-586

Martin Fernandez M, Arroyo V, Carnicero C, Siguenza R, Busta R, Mora N, et al. Role of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLD. Antioxidants. 2022; 11(11). DOI:10.3390/antiox11112217.

Guerrero Fernandez J, Gonzalez Peramato P, Rodriguez Estevez A, Alcazar Villar MJ, Audi Parera L, Azcona San Julian MC, et al. Consensus guide on prophylactic gonadectomy in different sex development. Endocrinol Diabetes Nutr. 2022; 69(8): 629-645. DOI:10.1016/j.endien.2022.10.002.

Velasco I, Vila L, Goya M, Oleaga A, de la Calle M, Santamaria FJ. Executive summary of the SEEN (Sociedad Espanola de Endocrinologia y Nutricion[Spanish Society of Endocrinology and Nutrition])-SEGO (Sociedad Espanola deGinecologia y Obstetricia [Spanish Society of Gynaecology and Obstetrics]) consensusdocument on the management of thyroid dysfunction during pregnancy. Endocrinol Diabetes Nutr. 2022. DOI:10.1016/j.endien.2022.11.008.

Lanes Iglesias S, Megido Armada A, Castano Gonzalez LA, Menendez Torre EL, Riano Galan I. Experience in diagnosis and treatment of prolactinomas in pediatric patients and young adults. Endocrinol Diabetes Nutr. 2022; 69(10): 911-913. DOI:10.1016/j.endien.2022.11.028.

Gomez Peralta F, Abreu C, Fernandez Rubio E, Cotovad L, Pujante P, Gaztambide S, et al. Efficacy of a Connected Insulin Pen Cap in People With Noncontrolled Type 1 Diabetes: A Multicenter Randomized Clinical Trial. Diabetes Care. 2022; 46(1): 206-208. DOI:10.2337/dc22-0525.

Greeley SAW, Polak M, Njolstad PR, Barbetti F, Williams R, Castano L, et al. ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2022; 23(8): 1188-1211. DOI:10.1111/pedi.13426.

Nogueiras R, Aspichueta P. Expanding the roles of the renin-angiotensin system: Drug-induced liver injury. J Hepatol. 2023; 78(3): 457-459. DOI:10.1016/j.jhep.2022.12.016.

Jauregibeitia I, Portune K, Gaztambide S, Rica I, Tueros I, Velasco O et al. Molecular Differences Based on Erythrocyte Fatty Acid Profile to Personalize Dietary Strategies between Adults and Children with Obesity. Metabolites. 2021; 11(1). DOI:10.3390/metabo11010043.

Nucci AM, Virtanen SM, Cuthbertson D, Ludvigsson J, Einberg U, Huot C et al. Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk. Diabetologia. 2021; 64(4): 826-835. DOI:10.1007/s00125-020-05358-3.

Sebastian delaCruz M, Gonzalez Moro I, Olazagoitia Garmendia A, Castellanos Rubio A, Santin I. The Role of lncRNAs in Gene Expression Regulation through mRNA Stabilization. Non-coding RNA. 2021; 7(1). DOI:10.3390/ncrna7010003.

Infante A, Gener B, Vazquez M, Olivares N, Arrieta A, Grau G et al. Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro-osteogenic paracrine response: TERCELOI clinical trial. Clin Transl Med. 2021; 11(1): 265-265. DOI:10.1002/ctm2.265.

Garcia Castano A, Madariaga L, Gomez Conde S, Cordo CLR, Lopez Iglesias M, Garcia Fernandez Y et al. Five patients with disorders of calcium metabolism presented with GCM2 gene variants. Sci Rep. 2021; 11(1): 2968-2968. DOI:10.1038/s41598-021-82661-y.

Urrutia I, Martin Nieto A, Martinez R, Casanovas Marsal JO, Aguayo A, Del Olmo J et al. Incidence of diabetes mellitus and associated risk factors in the adult population of the Basque country, Spain. Sci Rep. 2021; 11(1): 3016-3016. DOI:10.1038/s41598-021-82548-y.

Simon J, Goikoetxea Usandizaga N, Serrano Macia M, Fernandez Ramos D, Saenz de Urturi D, Gruskos JJ et al. Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASH. J Hepatol. 2021; 75(1): 34-45. DOI:10.1016/j.jhep.2021.01.043.

Gonzalez Moro I, Santin I. Long non-coding RNA-regulated pathways in pancreatic beta cells: Their role in diabetes. Int Rev Cell Mol Biol. 2021; 359: 325-355. DOI:10.1016/bs.ircmb.2021.02.007.

Gonzalez Romero F, Mestre D, Aurrekoetxea I, O'Rourke CJ, Andersen JB, Woodhoo A et al. E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment. Cancer Res. 2021; 81(11): 2874-2887. DOI:10.1158/0008-5472.CAN-20-2052.

Pinart M, Jeran S, Boeing H, Stelmach Mardas M, Standl M, Schulz H et al. Dietary Macronutrient Composition in Relation to Circulating HDL and Non-HDL Cholesterol: A Federated Individual-Level Analysis of Cross-Sectional Data from Adolescents and Adults in 8 European Studies. J Nutr. 2021; 151(8): 2317-2329. DOI:10.1093/jn/nxab077.

Zenarruzabeitia O, Astarloa Pando G, Terren I, Orrantia A, Perez Garay R, Seijas Betolaza I et al. T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19. Front Immunol. 2021; 12. DOI:10.3389/fimmu.2021.655934.

Gomez Conde S, Garcia Castano A, Aguirre M, Herrero M, Gondra L, Garcia Perez N et al. Molecular aspects and long-term outcome of patients with primary distal renal tubular acidosis. Pediatr Nephrol. 2021; 36(10): 3133-3142. DOI:10.1007/s00467-021-05066-z.

Jauregibeitia I, Portune K, Rica I, Tueros I, Velasco O, Grau G et al. Potential of Erythrocyte Membrane Lipid Profile as a Novel Inflammatory Biomarker to Distinguish Metabolically Healthy Obesity in Children. J Pers Med. 2021; 11(5). DOI:10.3390/jpm11050337.

Ampuero J, Aller R, Gallego Duran R, Crespo J, Abad J, Gonzalez Rodriguez A et al. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects. Liver Int. 2021; 41(9): 2076-2086. DOI:10.1111/liv.14898.

Cabrera D, Rao I, Raasch F, Solis N, Pizarro M, Freire M et al. Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice. Ann Hepatol. 2021; 24: 100357-100357. DOI:10.1016/j.aohep.2021.100357.

Villalabeitia Ateca I, Perfecto Valero A, Serrano Hermosilla C, Marcaida Salazar A, Perez Fernandez S, Sarriugarte Lasarte A. Prognostic value of the nodal ratio in gastric cancer: Unicentric analysis pf 199 patients. Cir Esp (Engl Ed). 2021. DOI:10.1016/j.ciresp.2021.03.018.

Gonzalez Moro MB, Gonzalez Moro I, de la Pena M, Estavillo JM, Aparicio Tejo PM, Marino D et al. A Multi-Species Analysis Defines Anaplerotic Enzymes and Amides as Metabolic Markers for Ammonium Nutrition. Front Plant Sci. 2021; 11. DOI:10.3389/fpls.2020.632285.

Ludvigsson J, Sumnik Z, Pelikanova T, Nattero Chavez L, Lundberg E, Rica I et al. Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial. Diabetes Care. 2021. DOI:10.2337/dc21-0318.

Morales C, Bellido V, Tejera C, Goni F, Palomares R, Sevillano C et al. DAPA-RWE: a retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain. J Comp Eff Res. 2021; 10(10): 815-821. DOI:10.2217/cer-2020-0264.

Santamaria Sandi J, Navarro Gonzalez E, Herrero Ruiz A, Bandres Nivela O, Ballesteros Pomar M, Escalada San Martin FJ et al. Portfolio of services in Endocrinology and Nutrition. 2020 update. Endocrinol Diabetes Nutricion. 2021. DOI:10.1016/j.endinu.2021.01.006.

Pacaud D, Nucci AM, Cuthbertson D, Becker DJ, Virtanen SM, Ludvigsson J et al. Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes. Diabetologia. 2021; 64(1): 119-128. DOI:10.1007/s00125-020-05287-1.

Gonzalez Fenandez M, Antonio IED, Martin IMP, Martinez JS, Almaraz MCA. 5-Alpha-reductase type 2 deficiency. A new case in the Spanish population. Endocrinol Diabetes Nutricion. 2021. DOI:10.1016/j.endinu.2021.04.003.

Serrano Macia M, Simon J, Gonzalez Rellan MJ, Azkargorta M, Goikoetxea Usandizaga N, Lopitz Otsoa F et al. Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis. Mol Metab. 2021; 53: 101275-101275. DOI:10.1016/j.molmet.2021.101275.

Arif E, Wang C, Swiderska Syn MK, Solanki AK, Rahman B, Manka PP et al. Targeting myosin 1c inhibits murine hepatic fibrogenesis. Am J Physiol-Gastroint Liver Physiol. 2021; 320(6): 1044-1053. DOI:10.1152/ajpgi.00105.2021.

Borobia AM, Carcas AJ, Perez Olmeda M, Castano L, Bertran MJ, Garcia Perez J et al. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet. 2021; 398(10295): 121-130. DOI:10.1016/S0140-6736(21)01420-3.

Fernandez U, Fernandez Fondevila M, Gonzalez Rellan MJ, Da Silva Lima N, Buque X, Gonzalez A et al. Hepatic LPI/GPR55 systemregulates the development of non-alcoholic steatosis and steatohepatitis. J Hepatol. 2021; 75: 389-391

Simon J, Goikoetxea N, Serrano Macia M, Fernandez Ramos D, Saenz de Urturi D, Gruskos J et al. Hepatic magnesium accumulation upon cyclin M4 (CNNM4) silencing improves NASH. J Hepatol. 2021; 75: 612-612

Novoa E, da Silva Lima N, Fernandez Fondevila M, Buque X, Jesus Gonzalez M, Fernandez U et al. inhibition of atg3 ameliorates liver steatosis by increasing sirt1 in an autophagic-independent action. J Hepatol. 2021; 75: 591-591

Lee Law PY, Olaizola P, Caballero Camino FJ, Izquierdo Sanchez L, Rodrigues PM, Perugorria MJ et al. Inhibition of NAE-dependent protein hyper-NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease. United European Gastroenterol J. 2021; 9(7): 848-859. DOI:10.1002/ueg2.12126.

Serrano Macia M, Simon Espinosa J, Gonzalez Rellan MJ, Goikoetxea N, Azkargorta M, Lopitz Otsoa F et al. Neddylation inhibition reduces liver steatosis in MAFLD mice models by promoting hepatic fatty acid oxidation via DEPTOR-mTOR axis. J Hepatol. 2021; 75: 624-624

Gonzalez Romero F, Mestre Congregado D, Aurrekoetxea I, Rourke CO, Andersen J, Woodhoo A et al. Repression of fatty acid oxidation in steatohepatitic-HCC is mediated by E2F1 and E2F2 transcription factors. J Hepatol. 2021; 75: 497-498

Martinez de LaPiscina I, Portillo Najera N, Rica I, Gaztambide S, Webb S, Santos A et al. Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas. Eur J Endocrinol. 2021; 185(4): 485-496. DOI:10.1530/EJE-21-0075.

Gonzalez Moro I, Sebastian delaCruz M, Rojas Marquez H, Olazagoitia Garmendia A, Mentxaka J, Mendoza LM et al. A long non-coding RNA that harbors a SNP associated with insulin levels regulates TGM2 gene expression in pancreatic beta cells. Diabetologia. 2021; 64(SUPPL 1): 8-9

Garcia Escobar E, Valdes S, Soriguer F, Vendrell J, Urrutia Etxebarria IM, Maldonado Araque C et al. Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study. Sci Rep. 2021; 11(1). DOI:10.1038/s41598-021-95546-x.

da Silva Lima N, Fondevila MF, Novoa E, Buque X, Mercado Gomez M, Gallet S et al. Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function. J Hepatol. 2021; 76(1): 11-24. DOI:10.1016/j.jhep.2021.09.008.

Zurita ALP, Appelman Dijkstra N, Biermasz N, Bryce J, Burman P, Castano L et al. The Pituitary Tumour Module: Developing a Condition Specific Module within the European Registries for Rare Endocrine Conditions (EuRRECa). Horm Res Paediatr. 2021; 94(SUPPL 1): 113-113

Martinez de LaPiscina I, Portillo N, Rica I, Gaztambide S, Castano L. Sporadic pituitary adenomas in young patients: clinical and molecular description. Horm Res Paediatr. 2021; 94(SUPPL 1): 108-109

Mejia de Beldjenna L, Garcia Castano A, Gomez Conde S, Castano L. Primary hyperparathyroidism due to a deletion of the CDC73 gene. Horm Res Paediatr. 2021; 94(SUPPL 1): 215-215

Doulatram Gamgaram V, Valdes S, Maldonado Araque C, Lago Sampedro A, Badia Guillen R, Garcia Escobar E et al. Association between long term exposure to particulate matter and incident hypertension in Spain. Sci Rep. 2021; 11(1). DOI:10.1038/s41598-021-99154-7.

Madariaga L, Gomez Conde S, Garcia Castano A, Aguirre M, Herrero M, Gondra L et al. LONG-TERM OUTCOME OF A SERIES OF PATIENTS WITH PRIMARY DISTAL RENAL TUBULAR ACIDOSIS. Pediatr Nephrol. 2021; 36(10): 3367-3367

Martinez de LaPiscina I, Fluck CE. Genetics of human sexual development and related disorders. CURR OPIN PEDIATR. 2021; 33(6): 556-563. DOI:10.1097/MOP.0000000000001066.

Chueca MJ, Grau G, Bertholt L, Artola E, Fernandez C, Sarasua A et al. TBG deficiency and Central Congenital Hypothyroidism (CCH): Our experience in neonatal screening with TSH and T4. Horm Res Paediatr. 2021; 94(SUPPL 1): 417-418

Rica I, Garcia M, Grau G, Vela A, Rodriguez A, Luisa Guadilla M. Is the recommended dual therapy for transsexual boys harmless?. Horm Res Paediatr. 2021; 94(SUPPL 1): 381-382

Grau G, Laura Bertholt M, Chueca M, Artola E, Concepcion Fernandez M, Sarasua A et al. Early reassessment in congenital hypothyroidism. Horm Res Paediatr. 2021; 94(SUPPL 1): 407-408

Vela A, Regina Gonzalez M, Diaz C, Elorza A, Grau G, Rodriguez A et al. Anthropometric and clinical situation in two groups of young adults born Small for Gestational Age (a group with catch-up and another without catch-up and treated with Growth Hormone). Horm Res Paediatr. 2021; 94(SUPPL 1): 278-279

Diez JJ, Anda E, Sastre J, Corral BP, alvarez Escola C, Manjon L et al. Late Recovery of Parathyroid Function after Total Thyroidectomy: A Case-Control Study (Sep, 10.1055/a-1646-8410, 2021). HORM METAB RES. 2021. DOI:10.1055/a-1646-8410.

Diez JJ, Anda E, Sastre J, Corral BP, alvarez Escola C, Manjon L et al. Late Recovery of Parathyroid Function after Total Thyroidectomy: A Case-Control Study. HORM METAB RES. 2021; 53(10): 654-661. DOI:10.1055/a-1608-1373.

Maritxalar AI, Goni MH, Dominguez LM, Sangroniz LG, Menica MA, Castano AG et al. OUTCOME OF A COHORT OF PATIENTS WITH DENT DISEASE. Pediatr Nephrol. 2021; 36(10): 3312-3312

Sangroniz LG, Dominguez LM, Castano AG, Goni MH, Menica MA, Jaca AV et al. LONG-TERM FOLLOW-UP OF PATIENTS WITH BARTTER SYNDROME TYPE III. Pediatr Nephrol. 2021; 36(10): 3302-3303

Kouri C, Sommer G, Ahmed F, Balsamo A, Baronio F, Bryce J et al. Broad range of phenotypes in an international cohort of 75 DSD individuals with SF-1/NR5A1 variants. Horm Res Paediatr. 2021; 94(SUPPL 1): 87-89

Estevez Vazquez O, Benede Ubieto R, Guo F, Gomez Santos B, Aspichueta P, Reissing J et al. Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD). Biomedicines. 2021; 9(10). DOI:10.3390/biomedicines9101289.

Perez Valle A, Abad Garcia B, Fresnedo O, Barreda Gomez G, Aspichueta P, Asumendi A et al. A UHPLC-Mass Spectrometry View of Human Melanocytic Cells Uncovers Potential Lipid Biomarkers of Melanoma. Int J Mol Sci. 2021; 22(21). DOI:10.3390/ijms222112061.

Alonso SP, Valdes S, Maldonado Araque C, Lago A, Ocon P, Calle A et al. Thyroid hormone resistance index and mortality in euthyroid subjects: Di@bet.es study. Eur J Endocrinol. 2021; 186(1): 95-103. DOI:10.1530/EJE-21-0640.

Santamans AM, Montalvo Romeral V, Mora A, Lopez JA, Gonzalez Romero F, Jimenez Blasco D et al. p38gamma and p38delta regulate postnatal cardiac metabolism through glycogen synthase 1. PLoS Biol. 2021; 19(11). DOI:10.1371/journal.pbio.3001447.

Fernandez LS, Iturriaga LAR, Yandiola PPE, Ocana RM, Fernandez SP, Huget ET et al. BACTERAEMIC PNEUMOCOCCAL PNEUMONIA AND SARS-CoV-2 PNEUMONIA: DIFFERENCES AND SIMILARITIES. Int J Infect Dis. 2021; 115: 39-47. DOI:10.1016/j.ijid.2021.11.023.

Serrano Macia M, Espinosa JS, Gonzalez Rellan MJ, Azkargorta M, Goikoetxea Usandizaga N, Lopitz Otsoa F et al. NEDDYLATION INHIBITION REDUCES LIVER STEATOSIS IN MAFLD MICE MODELS BY PROMOTING HEPATIC FATTY ACID OXIDATION VIA DEPTOR-mTOR AXIS. Hepatology. 2021; 74: 1146-1147

Espinosa JS, Goikoetxea Usandizaga N, Serrano Macia M, Ramos DF, De Urturi DS, Gruskos JJ et al. MAGNESIUM ACCUMULATION UPON CYCLIN M4 SILENCING AMELIORATES NON-ALCOHOLIC STEATOHEPATITIS. Hepatology. 2021; 74: 1143-1144

Cardon EB, Arrospide A, Ugarte HA, Etxebarria IU, Gonzalez LG, Etxebarria I et al. Diet as a risk factor for hypovitaminosis D in the Spanish pediatric population. Rev Osteoporos Metab Min. 2021; 13(4): 122-129. DOI:10.4321/S1889-836X2021000300004.

Sonia G, Button EA, Zulueta M, Arana E, de la Hoz AB, Mendizabal L et al. Association of Serum 1,5-Anhydroglucitol with Severe COVID-19 in T2D patients. Diabetes. 2021; 70. DOI:10.2337/db21-146-LB.

Munoz RN, Ortega YC, Sarmiento M, Jorge RV, Herrero MN, Subirats JG et al. Postoperative basal serum thyroglobuline (TG) prior to radioiodine therapy as a predictive factor of recurrence in patients with differentiated thyroid cancer (DTC). Eur J Nucl Med Mol Imaging. 2021; 48(SUPPL 1): 436-436

Ecenarro PS, Marina N, Perez Fernandez S, Tabernero E, Iriberri M, Celli B. Paradoxical bronchoconstriction after administration of beta-2 agonist bronchodilators in COPD patients. Eur Resp J. 2021; 58. DOI:10.1183/13993003.congress-2021.PA3437.

Iturriaga L, Fernandez LS, Quero BG, Bonilla AG, Fernandez SP, Carasusan AR et al. Lymphopenic community acquired pneumococcal pneumonia: Clinical characteristics and outcome. Eur Resp J. 2021; 58. DOI:10.1183/13993003.congress-2021.PA1749.

Fernandez LS, Iturriaga L, Yandiola P, Ocana RM, Fernandez SP, Huget ET et al. Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities. Eur Resp J. 2021; 58. DOI:10.1183/13993003.congress-2021.PA1750.

Pando GA, Zenarruzabeitia O, Terren I, Orrantia A, Garay RP, Betolaza IS et al. T cell activation, highly armed cytotoxic cells and a shift in monocytes CD300 receptors expression in severe COVID-19. Eur J Immunol. 2021; 51: 267-267

Oyanguren J, Diaz Molina B, Lekuona I, Gonzalez Costello J, Lopez Fernandez S, Garcia Pinilla JM et al. Gender differences in drug titration among heart failure patients with reduced ejection fraction in the ETIFIC trial. Rev Esp Cardiol (Engl Ed). 2021. DOI:10.1016/j.rec.2021.11.002.

Orrantia A, Terren I, Pando GA, Gonzalez C, Uranga A, Mazon JJM et al. High frequency of mature CD57+NKG2A-NK cells associate with poor disease progression after autologous hematopoietic stem cell transplantation in multiple myeloma patients. Eur J Immunol. 2021; 51: 271-271

Tesis del grupo

Autor/a: Inés Urrutia Etxebarria . Título: "Secuenciación masiva aplicada al diagnóstico de diabetes monogénica en pacientes pediátricos con sospecha de diabetes tipo 1 y marcadores de autoinmunidad negativos". Directores/as: Dr. Luis Antonio Castaño González, Dr. José Ramón Bilbao Catalá.

Autor/a: Victoria Díez Bayona. Título: "Análisis del perfil inflamatorio, clínico y nutricional de la enfermedad celiaca al diagnóstico y tras la implantación de la dieta sin gluten ". Director/a: Dr. Luis Antonio Castaño González.

Autor/a: Leire Gondra Sangroniz. Título: "Evolución clínica de los pacientes con síndrome de Bartter tipo III". Directores/as: Dr. Luis Antonio Castaño González, Dra. Leire Madariaga Domínguez.

Autor/a: Sonia Pérez San Martín. Título: "Estatus nutricional de la vitamina D y metabolismo fosfocálcico en la sepsis. Relación del metabolismo de la vitamina D con la inflamación en la sepsis". Director/a: Dra. Sonia Gaztambide Saenz.

Autor/a: Idoia Martínez de Lapiscina Martin. Título: "Clinical ande molecular characterization of DSD patients: Impact of next generation sequencing in diagnosis ". Directores/as: Dr. Luis Castaño González, Dr. José Ramón Bilbao Catalá.

Autor/a: Daniel Eceizabarrena Perez . Título: "A geometric and physical study of Riemann’s non-diferentiable function. ". Director/a: Dr. Luis Vega González.

Autor/a: Mikel Aguirre Alonso. Título: "The Schrödinger Equaton and Uncertainty Principles. ". Director/a: Dr. Luis Vega González.

Autor/a: Sandeep Kumar. Título: "Vortex Filament Equation for some Regular Polygonal Curves. ". Directores/as: Dr. Luis Vega González, Dr. Francisco de la Hoz Méndez.

Autor/a: Aitor de la Quintana Basarrate. Título: "La neuromonitorización continua del nervio recurrente durante la tiroidectomía". Director/a: Dra. Sonia Gaztambide Sáenz.

Autor/a: María Victoria Aparicio Prieto. Título: Fragmentación del ADN espermático y su relación con el metabolismo peptídico. Directores: Dr. Luis Casis Saenz, Dra. Nerea Subirán Ciudad.

Autor/a: Teresa Velayos Gainza. Título: ""Respuesta clínica en pacientes con cáncer colorrectal metastásico y farmacodinamia del irinotecán en los mismos"". Directores/as: Dr. Luis Antonio Castaño González, Dra. Izortze Santín Gómez.

Autor/a: María Pilar Vela Orús. Título: Isquemia crítica en pacientes diabéticos ¿Es válida la nueva clasificación WIfI?. Director/a: Dra. Sonia Gaztambide Sáenz. UPV/EHU

Responsive Image

Plaza Cruces S/N | 48903 Barakaldo
Tel.: 94 618 26 22

© 2024 IIS Biobizkaia